| 000 | 01692 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516153311.0 | ||
| 264 | 0 | _c20140127 | |
| 008 | 201401s 0 0 eng d | ||
| 022 | _a1573-7217 | ||
| 024 | 7 |
_a10.1007/s10549-013-2579-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBjöhle, J | |
| 245 | 0 | 0 |
_aSerum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial. _h[electronic resource] |
| 260 |
_bBreast cancer research and treatment _cJun 2013 |
||
| 300 |
_a751-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 |
_aBreast Neoplasms _xblood |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMucin-1 _xblood |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aThymidine Kinase _xblood |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBergqvist, J | |
| 700 | 1 | _aGronowitz, J S | |
| 700 | 1 | _aJohansson, H | |
| 700 | 1 | _aCarlsson, L | |
| 700 | 1 | _aEinbeigi, Z | |
| 700 | 1 | _aLinderholm, B | |
| 700 | 1 | _aLoman, N | |
| 700 | 1 | _aMalmberg, M | |
| 700 | 1 | _aSöderberg, M | |
| 700 | 1 | _aSundquist, M | |
| 700 | 1 | _aWalz, T M | |
| 700 | 1 | _aFernö, M | |
| 700 | 1 | _aBergh, J | |
| 700 | 1 | _aHatschek, T | |
| 773 | 0 |
_tBreast cancer research and treatment _gvol. 139 _gno. 3 _gp. 751-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10549-013-2579-x _zAvailable from publisher's website |
| 999 |
_c22808503 _d22808503 |
||